Ursa Major Hadley Engine Flies for the First Time
Ursa Major and Stratolaunch achieve a major leap toward the first flight test of a privately funded hypersonic vehicle DENVER, March 9, 2024 /PRNewswire/ — Ursa Major’s Hadley engine, a purpose-built engine to satisfy America’s commercial and national security space needs, flew fo
Stratolaunch Celebrates First Powered Flight of TA-1 Test Vehicle
MOJAVE, Calif., March 9, 2024 /PRNewswire/ — Stratolaunch, LLC is pleased to announce it has successfully completed the first powered flight of the Talon-A test vehicle, TA-1. This first flight represents a major milestone in the development of the country’s first privately funded, reu
Media Advisory – Prime Minister’s itinerary for Sunday, March 10, 2024
OTTAWA, ON, March 9, 2024 /CNW/ – Note: All times local National Capital Region, Canada No public events scheduled This document is also available at https://pm.gc.ca SOURCE Prime Minister’s Office
Media Advisory – Prime Minister’s itinerary for Sunday, March 10, 2024
OTTAWA, ON, March 9, 2024 /CNW/ – Note: All times local National Capital Region, Canada No public events scheduled This document is also available at https://pm.gc.ca SOURCE Prime Minister’s Office
Stratolaunch Celebrates First Powered Flight of TA-1 Test Vehicle
MOJAVE, Calif., March 9, 2024 /PRNewswire/ — Stratolaunch, LLC is pleased to announce it has successfully completed the first powered flight of the Talon-A test vehicle, TA-1. This first flight represents a major milestone in the development of the country’s first privately funded, reu
Y-COM Announces Rob Hughart as Chief Executive Officer
MELBOURNE, Fla., March 9, 2024 /PRNewswire/ — Young’s Communications, LLC (“Y-COM” or the “Company”), a premier Florida-based construction services provider to telecommunications, utility, and power infrastructure companies, backed by Grain Management, LLC (“
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRTC
NEW YORK, March 9, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of iRhythm Technologies, Inc. (NASDAQ: IRTC) between January 11, 2022 and May 30, 2023, both dates inclusive (the “Class Period”), of the important Apri
First Presentation of Year 4 BIMZELX® (bimekizumab-bkzx) Data Showed Long-Term Maintenance of Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis
Late-breaking platform presentation showed that BIMZELX® (bimekizumab-bkzx) rapidly achieved and maintained high rates of clinical and health-related quality-of-life responses through four years; six out of ten patients achieved complete skin clearance at Year 4Responder-analyses demonstrated that
New data shows JNJ-2113, the first and only investigational targeted oral peptide, maintained skin clearance in moderate-to-severe plaque psoriasis through one year
JNJ-2113 long-term extension FRONTIER 2 study demonstrated sustained efficacy from Week 16 to Week 52 and safety results consistent with previously reported data (FRONTIER 1 Study) in a late-breaking oral presentation at the American Academy of Dermatology 2024 Annual Meeting SAN DIEGO, March 9,
Pelage Presents Late-Breaking Data at AAD 2024 Meeting Demonstrating PP405 Activates Human Hair Follicle Stem Cells Ex Vivo and in Phase 1 Clinical Study
– Potent topical MPC inhibitor, based on discovery of a metabolic switch, reawakens dormant hair follicle stem cells to stimulate hair growth – PP405 demonstrates statistically significant activation of Ki67 in the hair follicle, a well-established marker of stem cell proliferation LOS
